SpineGuard announced the filing of its 510K regulatory dossier in the US with the FDA, seeking clearance to commercialize its new device designed to secure the Posterior sacroiliac Fusion (PsiF) surgical procedure.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1578 EUR | +0.51% |
|
-3.90% | -20.94% |
06:00pm | SpineGuard Files Its 510K Dossier in the Us for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | CI |
07-16 | SpineGuard: growth accelerates in Q2 | CF |
1st Jan change | Capi. | |
---|---|---|
-20.94% | 9.13M | |
+75.69% | 12.57B | |
-19.75% | 7.63B | |
-5.38% | 5.84B | |
+10.32% | 5.16B | |
-16.50% | 4.75B | |
-12.24% | 4.17B | |
+17.06% | 4.16B | |
-9.72% | 3.37B | |
+26.99% | 2.07B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard Files Its 510K Dossier in the Us for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion